Mural Oncology (MURA) News Today $1.47 -2.36 (-61.62%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$1.46 0.00 (-0.34%) As of 08:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Raymond James downgrades Mural Oncology after ovarian cancer failureMarch 26 at 4:51 AM | markets.businessinsider.comMural Oncology halting progress of nemvaleukin trial in ovarian cancerMarch 26 at 4:51 AM | markets.businessinsider.comMural Oncology (NASDAQ:MURA) Rating Lowered to Equal Weight at Morgan StanleyMarch 26 at 2:38 AM | americanbankingnews.comJones Trading Downgrades Mural Oncology (MURA)March 25 at 6:49 PM | msn.comMural Oncology to Discontinue Ovarian Cancer Drug Candidate as Trial Misses TargetsMarch 25 at 6:49 PM | marketwatch.comAlkermes spinoff Mural plunges on plans to halt ovarian cancer trialMarch 25 at 6:49 PM | msn.comMural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57%March 25 at 6:49 PM | finance.yahoo.comMural Oncology's Ovarian Cancer Combo Drug Trial Disappoints, Stock PlungesMarch 25 at 10:02 AM | benzinga.comMural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian CancerMarch 25 at 6:30 AM | globenewswire.comMural Oncology (MURA) Projected to Post Earnings on TuesdayMarch 23 at 1:27 AM | americanbankingnews.comMural Oncology (MURA) Expected to Announce Earnings on TuesdayMural Oncology (NASDAQ:MURA) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.comQ1 EPS Estimates for Mural Oncology Lowered by HC WainwrightMarch 18, 2025 | americanbankingnews.comQ1 EPS Estimates for Mural Oncology Reduced by HC WainwrightMural Oncology plc (NASDAQ:MURA - Free Report) - Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Mural Oncology in a research report issued to clients and investors on Wednesday, March 12th. HC Wainwright analyst A. Maldonado now anticipates that the company will earnMarch 17, 2025 | marketbeat.comMural Oncology enters agreement for share salesMarch 13, 2025 | investing.comHC Wainwright Reiterates "Buy" Rating for Mural Oncology (NASDAQ:MURA)HC Wainwright reiterated a "buy" rating and set a $18.00 target price on shares of Mural Oncology in a research report on Wednesday.March 13, 2025 | marketbeat.comMural Oncology (NASDAQ:MURA) Issues Earnings Results, Misses Expectations By $0.05 EPSMural Oncology (NASDAQ:MURA - Get Free Report) announced its earnings results on Tuesday. The company reported ($2.01) earnings per share for the quarter, missing analysts' consensus estimates of ($1.96) by ($0.05).March 12, 2025 | marketbeat.comAnalysts Offer Insights on NA Companies: Viking Holdings Ltd (VIK) and Mural Oncology Plc (MURA)March 12, 2025 | markets.businessinsider.comMural Oncology reports Q4 EPS ($2.01), consensus ($1.96)March 11, 2025 | markets.businessinsider.comMural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical MilestonesMarch 11, 2025 | globenewswire.comMural Oncology (NASDAQ:MURA) Stock Price Up 1.4% - Here's WhyMural Oncology (NASDAQ:MURA) Trading Up 1.4% - Here's WhyMarch 8, 2025 | marketbeat.comNew mural at St. Christopher's Hospital for Children in North Philadelphia raises mental health awarenessFebruary 19, 2025 | msn.comMural Oncology to Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 18, 2025 | globenewswire.comMural Oncology plc (NASDAQ:MURA) Short Interest UpdateMural Oncology plc (NASDAQ:MURA - Get Free Report) was the target of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 396,800 shares, a drop of 25.2% from the January 15th total of 530,200 shares. Based on an average daily volume of 206,900 shares, the short-interest ratio is presently 1.9 days. Currently, 2.6% of the shares of the company are short sold.February 15, 2025 | marketbeat.comMural Oncology (NASDAQ:MURA) Trading 8.8% Higher - Here's WhyMural Oncology (NASDAQ:MURA) Trading Up 8.8% - Here's What HappenedFebruary 7, 2025 | marketbeat.comTwin Falls High School senior, cancer survivor brightens up the hallways with a muralJanuary 31, 2025 | msn.comJones Trading Initiates Coverage of Mural Oncology (MURA) with Buy RecommendationJanuary 28, 2025 | msn.comJones Trading sets $16 target on Mural Oncology stockJanuary 27, 2025 | msn.comJonesTrading Initiates a Buy Rating on Mural Oncology Plc (MURA)January 27, 2025 | markets.businessinsider.comMural Oncology initiated with a Buy at JonesResearchJanuary 27, 2025 | markets.businessinsider.comMural Oncology Highlights Pipeline Progress and Anticipated 2025 CatalystsJanuary 9, 2025 | globenewswire.comLouis Nelson, Designer of Korean War Mural, Dies at 88December 14, 2024 | nytimes.comVerition Fund Management LLC Reduces Position in Mural Oncology plc (NASDAQ:MURA)Verition Fund Management LLC decreased its stake in shares of Mural Oncology plc (NASDAQ:MURA - Free Report) by 33.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 340,000 shares of the company's stocDecember 9, 2024 | marketbeat.comMural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 3, 2024 | globenewswire.comAnalysts Give Strong Buy Rating To This Undervalued Medical Stock (MURA) With Up To 350% Of Share Price UpsideDecember 2, 2024 | finance.yahoo.comMural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of CancerNovember 20, 2024 | globenewswire.comHC Wainwright Raises Earnings Estimates for Mural OncologyMural Oncology plc (NASDAQ:MURA - Free Report) - Stock analysts at HC Wainwright raised their FY2024 earnings per share estimates for Mural Oncology in a research report issued to clients and investors on Wednesday, November 13th. HC Wainwright analyst A. Maldonado now anticipates that the companNovember 18, 2024 | marketbeat.comMural Oncology files $300M mixed securities shelfNovember 14, 2024 | markets.businessinsider.comPromising Developments in Mural Oncology Plc’s Pipeline Reinforce Buy RatingNovember 14, 2024 | markets.businessinsider.comTampa General Hospital receives $8.5M gift to establish breast cancer centerNovember 13, 2024 | bizjournals.comBuy Rating for Mural Oncology Plc Driven by Innovative Therapies and Promising Clinical DataNovember 13, 2024 | markets.businessinsider.comMural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline ProgressNovember 13, 2024 | markets.businessinsider.comMural Oncology's (MURA) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $18.00 price objective on shares of Mural Oncology in a report on Monday.November 11, 2024 | marketbeat.comMural Oncology to Participate in Two Upcoming Investor ConferencesNovember 11, 2024 | globenewswire.comMural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)November 7, 2024 | globenewswire.com"We're giving the middle finger to burglars by creating something beautiful where they left scars"November 6, 2024 | msn.comBruins honor Jack Edwards at TD Garden with pregame ceremony, muralNovember 5, 2024 | msn.comMural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 4, 2024 | globenewswire.comInsider Selling: Mural Oncology plc (NASDAQ:MURA) CFO Sells 7,421 Shares of StockNovember 2, 2024 | insidertrades.comMichelangelo ‘painted woman with breast cancer’November 1, 2024 | msn.com‘I wanted her memory to last forever:’ York County mural dedicated to late grandmotherNovember 1, 2024 | msn.com Remove Ads Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address MURA Media Mentions By Week MURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MURA News Sentiment▼-0.600.79▲Average Medical News Sentiment MURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MURA Articles This Week▼143▲MURA Articles Average Week Remove Ads Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Design Therapeutics News Today Terns Pharmaceuticals News Today Acelyrin News Today Cardiff Oncology News Today UroGen Pharma News Today Atea Pharmaceuticals News Today Immutep News Today enGene News Today DiaMedica Therapeutics News Today Foghorn Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MURA) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MURA Stock Free MURA Stock Alerts